- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 102,980 | 01.10.24 11:39:47 | +0,080 | +0,08% | 103,200 | 103,260 | 103,520 | 102,900 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 947,400 | 01.10.24 12:19:56 | +4,800 | +0,51% | 942,400 | 948,400 | 936,800 | 942,600 |
